We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 546

SCOTUS sides with FTC in reverse payment deals
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

A divided U.S. Supreme Court has determined that patent-infringement settlement agreements requiring the patentee to pay the claimed infringer


Legislation would allow extended protection for biologics method of use patents
  • Shook Hardy & Bacon LLP
  • USA
  • April 3 2014

Democrats in the U.S. House and senate have introduced companion bills (H.R. 4287; S. 2150) that would allow the owner, or its agent, of a "patent


U.S. Supreme Court considers patentability of computer software
  • Shook Hardy & Bacon LLP
  • USA
  • April 3 2014

The U.S. supreme Court has heard oral argument in a case, which raised significant interest in the technology community and generated dozens of


Senators seek clarity on mobile medical apps
  • Shook Hardy & Bacon LLP
  • USA
  • April 3 2014

Seeking clarification on the U.S. Food and Drug Administration's (FDA's) final guidance pertaining to Mobile Medical Applications (apps), a


Nagoya genetic resources protocol enters into force
  • Shook Hardy & Bacon LLP
  • Global, USA
  • October 30 2014

The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization entered into force


News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry titled "Circumstances that Constitute Delaying, Denying, Limiting


Third Circuit revives shareholder suit over dissolved biotech company
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

A divided Third Circuit Court of Appeals panel has reversed a district court ruling dismissing a shareholder's lawsuit against individuals and a


Physicians urge FDA to allow distinctive names for biosimilars
  • Shook Hardy & Bacon LLP
  • USA
  • August 21 2014

A coalition of organizations representing specialist physicians and individual physicians have authored a letter to U.S. Food and Drug Administration


Guilty plea entered in cancer-drug smuggling operation
  • Shook Hardy & Bacon LLP
  • USA
  • August 21 2014

The owner of an Istanbul, Turkey-based pharmaceutical company has pleaded guilty in a Missouri federal court to charges that he shipped illegal


Mexican health-care market estimated to gain 6.8 percent compounded annually
  • Shook Hardy & Bacon LLP
  • USA, Mexico
  • August 21 2014

Research and consulting firm GlobalData reports that Mexico's health-care market, including both the pharmaceutical and medical device sectors, will